Birdwatch Note Rating
2023-03-16 14:34:23 UTC - NOT_HELPFUL
Rated by Participant: E077F49469487BD362106606F1E3A09195766F36D87998F02D69F3B97220D537
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details